CTOs on the Move

Innova Medical Group

www.innovamedgroup.com

 
Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions. Our strategic and iterative approach enables us to create, build and deploy a myriad of accessible tests customized to meet and empower the user at their point of need. With a panoramic vision spanning the present to the future, we develop trusted solutions that are both intuitive and secure to use. We quickly and nimbly became the world`s largest provider of COVID-19 tests, and we are determined to execute on this model across infectious disease, other chronic ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Tri-therapy Inc

Tri-therapy Inc is a Searcy, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

venus-concept

Venus Concept is a leading developer and manufacturer of devices for the medical aesthetic market.

edmonds womens clinic

edmonds womens clinic is a Edmonds, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Provista

Provista is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Transgenomic

Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.  Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.